Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study

open access 

 Highlights

•

We examined pre-diagnosis use of menopausal hormone therapy (MHT) and ovarian cancer-specific mortality.

•

Estrogen-only and estrogen plus progestin-only therapy were unrelated to ovarian cancer-specific death.

•

Recency of MHT use was unrelated to ovarian cancer-specific death.

•

Women who used MHT prior to ovarian cancer diagnosis do not experience higher mortality.